This text is a result of machine translation.
Oriental biology: Several monkeypox detection products have obtained EU CE certification
Major adjustment of Bayer's structure: combining cardiovascular and diabetes to establish the cancer business department
EqualOcean Sector Quarterly Report - Healthcare Sectors
To help worldwide investors keep track of what is happening in each industry or sector and the related hot spots, we launched the EqualOcean Sector Quarterly Report series, which gathers notable information and statistics in each quarter.
Apr 07, 2022 01:44 PM
The main board of HKEx is the largest digital comprehensive service platform for the pharmaceutical industry outside the hospital in China
Shuoxing biological innovative nano multi antibody sm3321 was approved by ind in the United States
Research
Healthcare, Technology, Consumer StaplesWIA2020 | Rising Tech Stars 2020: Global & China's 100
Research
Real Estate, Industrials, TechnologyTech for Global, Globalization Footprints of the Established and the New
Research
Real Estate, Industrials, TechnologyLow-Carbon Industry Expansion - Key Studies From Chinese Companies
Temasek's reduction of Cinda biological
Medtronic's world's first self expanding pulmonary valve was first-class recalled
Inactivated vaccine against novel coronavirus of Chinese medicine Zhongsheng Omicron mutant approved for clinical use
Healthcare Content Provider VanMul Receives Angle Round Funding
VanMul Health, a Chinese healthcare social media content provider, has received CNY 5 million in angel round funding. The company which founded less than a year ago, is taking a different approach to healthcare content on social media, forming deep partnerships with companies such as Douyin, Tencent, Roche, and Merck & Co.
May 27, 2022 01:50 PM
The new crown inactivated vaccine of Sinopharm Zhongsheng Omicron mutant was approved clinically.
Yanye said that its Xinguan oral drug s-217622 can quickly eliminate the virus
Bojian abandons Alzheimer's disease drug aduhelm and goes public in the EU
Services Provider Haixin Zhihui Raises CNY Hundreds of Mns in Series B Funding
Founded in January 2018, Haixin Zhihui is an artificial intelligence company focusing on the oncology field, it specializes in intelligent tumor diagnosis and treatment and has developed the first oncology intelligent diagnosis and treatment system in China.
May 25, 2022 04:04 PM
Upside foods, a cell meat enterprise, received US $400 million in financing, the highest single transaction in the industry
Lingfu biology, an experimental animal research service provider, completed a pre-A round of financing of more than 200 million yuan
Hefei Tiangang immunopharmaceutical Co., Ltd., a tumor immunotherapy enterprise, completed a round of pre-A financing of hundreds of millions of yuan
Ping An Health's 2021 annual report was released, with a revenue of 7.3 billion yuan, a year-on-year increase of 8%
Going Beyond Flat: Kandao QooCam EGO Transcends 'Metaverse' into the Real World
May 25, 2022 02:28 AM